Trials / Conditions / Transthyretin-Mediated Amyloidosis
Transthyretin-Mediated Amyloidosis
3 registered clinical trials studyying Transthyretin-Mediated Amyloidosis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study to Assess the PK, PD, Safety and Tolerability of Eplontersen in Healthy Chinese Volunteers NCT06527755 | AstraZeneca | Phase 1 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy NCT05661916 | Alnylam Pharmaceuticals | Phase 1 |
| Recruiting | ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyl NCT04561518 | Alnylam Pharmaceuticals | — |